Company: RPTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103764
Chunk: 64

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 64
---
 201(e) of RegulationS-K. |

| (3) | Net loss is as reported in our consolidated financial statements. |

<div align='center'>44</div>

|                                                                                                                                                                                                                                     |     |   2024 |            |   |     |                          |           |   |     |   2023 |            |   |     |                          |            |   |     |   2022 |            |   |     |                          |            |   |
| Year                                                                                                                                                                                                                                |     | PEO($) |            |   |     | Average ofNon-PEONEOs($) |           |   |     | PEO($) |            |   |     | Average ofNon-PEONEOs($) |            |   |     | PEO($) |            |   |     | Average ofNon-PEONEOs($) |            |   |
| Total from Summary Compensation Table                                                                                                                                                                                               |     |        |  2,368,837 |   |     |                          | 1,210,231 |   |     |        |  4,991,804 |   |     |                          |  2,010,970 |   |     |        |  4,021,395 |   |     |                          |  1,851,269 |   |
| Adjustments:                                                                                                                                                                                                                        |     |        |            |   |     |                          |           |   |     |        |            |   |     |                          |            |   |     |        |            |   |     |                          |            |   |
| Deduction for amounts reported under the “Stock Awards” and “Option Awards” columns of the Summary Compensation Table                                                                                                               |     |        | (1,481,960 | ) |     |                          |  (529,100 | ) |     |        | (4,059,623 | ) |     |                          | (1,348,330 | ) |     |        | (3,108,000 | ) |     |                          | (1,191,400 | ) |
| Increase (Decrease) for the inclusion of Rule 402(v) Equity Values:                                                                                                                                                                 |     |        |            |   |     |                          |           |   |     |        |            |   |     |                          |            |   |     |        |            |   |     |                          |            |   |
| Change in fair value of equity awards granted during the year that vested during